Clinical trial
Improving Tumor Oxygenation in Cervical Cancer
NCT00257829 · University of California, Irvine, Other · Withdrawn
Key facts
| NCT number | NCT00257829 |
|---|---|
| Title | Improving Tumor Oxygenation in Cervical Cancer |
| Official title | Improving Tumor Oxygenation in Cervical Cancer With Methazolamide |
| Lead sponsor | University of California, Irvine, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug |
| Interventions | Methazolamide, Cisplatin |
| Enrollment | 0 |
| Start date | Jul 1, 2004 |
| Primary completion | Sep 20, 2006 |
| Completion | Sep 20, 2006 |
| First posted | Nov 23, 2005 |
| Last update posted | Dec 3, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: